WHO ICTRP trial
Patient-derived-organoid Drug Sensitivity Screening and its Consistency with…
ChiCTR2200063320 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2200063320 |
|---|---|
| Public title | Patient-derived-organoid Drug Sensitivity Screening and its Consistency with Clinical Efficacy of Pan-cancer |
| Scientific title | Patient-derived-organoid Drug Sensitivity Screening and its Consistency with Clinical Efficacy of Pan-cancer |
| Primary sponsor | Qingdao Central Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | 0 |
| Countries | China |
| Conditions | solid tumor |
| Interventions | Case Series:Nil |
| Registration date | Sep 4, 2022 |
| Target size | Case Series:200 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: